Facilitating Successful Introduction of COVID-19 Vaccines
In a push to end the COVID-19 pandemic, the COVAX initiative, led by Gavi, the Coalition for Epidemic Preparedness Innovations, and WHO, is accelerating the process for rapid and equitable access to vaccines in low- and middle-income countries (LMICs). With several clinical trials completed and others under way, the first supply of the COVID-19 vaccine was available at the end of 2020. While current introduction and availability have been limited to high-income countries, LMICs must be ready to undertake the challenges of a COVID-19 vaccination campaign to reach global recovery from the pandemic.
Making decisions on COVID-19 vaccine options, introduction, deployment, and monitoring poses complex challenges to governments. Success depends on how key essential components are planned, implemented, monitored, and evaluated. MSH's strong country and local relationships and on-the-ground experience ensure rapid support to governments for the immediate, coordinated actions needed for timely access to and adequate and equitable distribution of the COVID-19 vaccine.